ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

25,308Medicare Part D Prescriptions Filled, Including Refills

Rank: 16 out of 680

$1.64M Total Retail Price of All Prescriptions

Rank: 17 out of 680

577 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
83% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 577 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

23% of this provider’s 577 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 21,616 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$65 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

44 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
HYDROCODONE-ACETAMINOPHEN 740 417 S3 1 4
LEVOTHYROXINE SODIUM 736 655 2 2
POTASSIUM CHLORIDE 679 586 3 14
FUROSEMIDE 664 597 4 6
AMLODIPINE BESYLATE 648 581 5 1
SIMVASTATIN 540 459 6 3
OMEPRAZOLE 531 475 7 7
DONEPEZIL HCL 495 483 8 27
NAMENDA 399 399 9 35
WARFARIN SODIUM 388 387 10 20
ATORVASTATIN CALCIUM 377 345 11 11
FAMOTIDINE 370 337 12 89
NEXIUM 362 246 13 16
LISINOPRIL 351 321 14 5
GLIMEPIRIDE 345 315 15 29
METFORMIN HCL 325 283 16 8
GABAPENTIN 320 283 17 15
TRAMADOL HCL 293 275 18 18
CLOPIDOGREL 286 248 19 26
CRESTOR 280 240 20 25
HYDROCHLOROTHIAZIDE 275 237 21 9
METOPROLOL TARTRATE 257 187 22 12
CARVEDILOL 256 221 23 23
SERTRALINE HCL 248 236 24 28
NOVOLOG FLEXPEN 245 159 25 189
TRAMADOL HCL-ACETAMINOPHEN 226 212 26 153
MIRTAZAPINE 224 201 27 78
TAMSULOSIN HCL 212 202 28 34
TRIAMTERENE-HCTZ 209 183 29 52
QUETIAPINE FUMARATE 205 188 30 64
ESCITALOPRAM OXALATE 199 154 31 45
LEVEMIR FLEXPEN 189 150 32 186
BISOPROLOL FUMARATE 187 174 33 173
CYMBALTA 182 161 34 46
LOSARTAN POTASSIUM 181 162 35 21
RANITIDINE HCL 173 137 36 56
ZOLPIDEM TARTRATE 173 143 36 17
CYCLOBENZAPRINE HCL 171 127 R 38 81
DIOVAN 170 169 39 31
PLAVIX 166 144 40 39
SULFAMETHOXAZOLE-TRIMETHOPRIM 162 139 41 94
CLONIDINE HCL 157 129 42 36
LIPITOR 153 130 43 68
AZITHROMYCIN 145 121 44 42
DEXILANT 138 97 45 171
CITALOPRAM HBR 138 130 45 22
TORSEMIDE 131 118 47 163
ALLOPURINOL 130 118 48 33
NYSTATIN 129 108 49 191
METOPROLOL SUCCINATE 126 112 50 13
PRAVASTATIN SODIUM 118 105 51 10
PANTOPRAZOLE SODIUM 117 113 52 30
ISOSORBIDE MONONITRATE ER 116 102 53 59
BYSTOLIC 116 92 53 79
ATENOLOL 114 111 55 19
DIGOXIN 112 101 56 58
MEGACE ES 111 103 R 57 280
EXELON 108 108 58 112
DOXYCYCLINE HYCLATE 107 91 59 95
AMLODIPINE BESYLATE-BENAZEPRIL 106 93 60 43
ALENDRONATE SODIUM 106 91 60 32
MELOXICAM 105 93 62 24
LANTUS 105 61 62 49
RAMIPRIL 105 91 62 69
POLYETHYLENE GLYCOL 3350 104 71 65 62
DILTIAZEM 24HR CD 104 104 65 182
GLIPIZIDE 98 94 67 63
PREDNISONE 96 78 68 50
ROPINIROLE HCL 95 70 69 99
ENALAPRIL MALEATE 93 80 70 65
SEROQUEL 92 85 71 123
VENLAFAXINE HCL ER 91 58 72 101
PROAIR HFA 90 68 73 67
ADVAIR DISKUS 88 72 74 53
ZIPRASIDONE HCL 88 47 74 229
PROMETHAZINE HCL 87 64 R 76 96
BUSPIRONE HCL 85 51 77 144
NIFEDIPINE ER 85 85 77 75
CIPROFLOXACIN HCL 80 70 79 57
RISPERIDONE 79 73 80 80
CARISOPRODOL 79 0 R 80 83
AMITRIPTYLINE HCL 79 51 R 80 47
CILOSTAZOL 77 77 83 230
KLOR-CON M10 76 76 84 127
INSULIN SYRINGE 75 64 85 86
NOVOFINE AUTOCOVER 75 53 85 248
LOVASTATIN 75 75 85 44
NASONEX 74 69 88 197
PENTOXIFYLLINE 73 73 89 356
DOXAZOSIN MESYLATE 72 57 90 73
FENTANYL 72 65 S2 90 183
PROPRANOLOL HCL 71 64 92 145
LIDODERM 70 70 93 221
SPIRIVA 68 68 94 70
FLUCONAZOLE 67 48 95 139
PREMARIN 66 65 R 96 105
JANUVIA 65 63 97 60
MEGESTROL ACETATE 65 64 R 97 88
SOTALOL 62 62 99 226
IBUPROFEN 60 53 100 126
LEVOFLOXACIN 60 44 100 97
CARBIDOPA-LEVODOPA 59 59 102 117
BENZTROPINE MESYLATE 59 51 R 102 137
ALPRAZOLAM 59 52 102 72
LUNESTA 58 54 105 252
CEPHALEXIN 58 51 105 149
HYDRALAZINE HCL 57 56 107 71
MUPIROCIN 57 39 107 130
FLUTICASONE PROPIONATE 57 36 107 41
CALCITRIOL 57 57 107 228
DILTIAZEM 24HR ER 56 48 111 132
NITROFURANTOIN MONO-MACRO 56 49 111 172
SYNTHROID 55 53 113 38
TIZANIDINE HCL 55 25 113 140
ENABLEX 55 55 113 217
SINGULAIR 54 48 116 91
PRAMIPEXOLE DIHYDROCHLORIDE 54 33 116 204
LEXAPRO 53 44 118 128
LYRICA 52 36 119 77
DIOVAN HCT 52 51 119 55
BENAZEPRIL HCL 51 51 121 40
OLANZAPINE 51 44 121 116
CELEBREX 51 47 121 90
LANSOPRAZOLE 51 37 121 184
LISINOPRIL-HYDROCHLOROTHIAZIDE 51 48 121 37
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 11, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.